In the "original script", Amgen Pharmaceutical's new drug finally modified the formula and process.

In Gordon S. M. Binder worked hard to find connections and pull investment. In the end, it survived this most important year before the new drug was launched.

The new drug sold $1 billion in the first year, and the exaggerated profit suddenly made Amgen Pharmaceutical, which was about to go bankrupt, not only survive the difficult year, but also the operation of the capital chain was normal.

It is precisely the normal launch of this new drug that keeps Amgen Pharmaceutical, the future world's No. 1 biopharmaceutical company, from falling halfway.

Just now.

There is still more than a year before the new drug is launched.

It was Amgen and Gordon M. M. Binder was at his most difficult.

There was a problem in the review of new drugs, the company's capital chain was broken, and it was unable to carry out experimental modifications of new formulas and manufacturing processes.

As a little over two years after the company's tenure, Gordon Brown has just been in charge of the company. M. Binder, I'm in a hurry. The president and CEO of his company, if his first pharmaceutical company to be the boss collapses less than two years after he took office.

Then my future in this industry will come to an end.

For this.

He's really gray-haired.

Coincidentally at this moment.

Abel sent such a message to the pharmaceutical industry, and Gordon J. Brown, who had learned about the deal between Abel and Pfizer, was said to be in the company. M. Binder, after a little discussion with the company's management and shareholders.

I had to come to the door hard.

He came to Abel for two main purposes. The first is the news that Abel revealed to the pharmaceutical industry that he is ready to cooperate with pharmaceutical companies to develop a new drug. And the second purpose is the real purpose of his trip, he came here - to attract investment.

Collaborating with a medical genius like Abel to develop a new drug is certainly an opportunity for a pharmaceutical company.

But it is the research and development of a new drug, from having ideas and ideas to officially launching. Except for a certain person who is open, the fastest process will take 5~7 years. Amgen Pharmaceutical's current situation will make it snicker if it can survive another year. How is it possible to develop a new drug that takes 5~7 years and requires a lot of capital and manpower investment with others?

Gordon S. M. Binder is here to invest!

The $300 million contract between Abel and Pfizer is the key to Gordon J. The reason why M. Binder came here.

Now Amgen Pharmaceutical is really a small point, although there is a drug that is being sold normally, but the annual sales are only 130 million US dollars. 130 million US dollars after deducting the publicity and distribution costs, as well as the production costs, the profit is about 70 million US dollars.

Although this profit seems to be amazing enough, you must know that Amgen Pharmaceutical's shareholders have invested more than $300 million in the research and development of this drug in the past 10 years, and this drug has only been on the market for a year, let alone making money, and even the research and development costs have not been recovered.

And that's not even counting the interest and principal on Amgen's loans from banks, and R&D costs from investment banks selling corporate bonds.

What's more, the company's annual operating expenses, as well as the R&D investment expenses of other new drugs, and the profit of 70 million a year, it is difficult to even maintain the normal operation of the company.

Desperate, Gordon Brown, a dead horse as a live horse doctor, M. Binder approached Abel to try.

See Abel's leisurely appearance.

Gordon S. M. Binder gritted his teeth and used the cheekiness of when he went to New York and Los Angeles to look for investment, and once again said cheekily:

"Mr. Sephorosa. Truth be told, I wonder if you've thought about investing in the pharmaceutical industry recently?"

"Uh-huh......" Abel dealt casually, knowing that it wasn't that he was rude.

It's because part of his current energy is focused on browsing the information about Amgen Medicine that Xiao Wrecking Ball has projected in his mind about the recent period.

It's just that his absent-minded appearance makes Gordon M. Binder suddenly felt a little cold.

The cheeky investors who were originally prepared were a little hesitant, not knowing whether they should open their mouths.

But for the sake of his own future and the future of the company, he still continued to bite the bullet and said:

"If you want to invest in the pharmaceutical industry now. Amgen Pharma has the best biopharmologists in the world, and I have read your papers published in the American Medical Journal and Biomedical and Pharmaceutical Therapy, and you are very optimistic about the future of biopharmaceuticals in your papers!"

Gordon S. After M. Binder finished speaking, he looked at Abel's face, and his heart was a little colder. Because this young genius didn't seem to be listening to himself at all, and he still looked absent-minded like just now.

Gordon S. M. Binder was a little angry in his heart, hey...... When will the days of begging grandpa and grandma to pull investment everywhere come to an end? M. Binder can only continue to speak cheekily:

"Amgen Pharma happens to be in the field of biopharmaceuticals and has a very good R&D strength. If you invest in Amgen, it won't take long! After next year, you will reap unimaginable returns!"

"Yes. ”

This time Abel finally replied to him, and the reason was simple. Because Abel has almost finished reading the information given to him by Xiao Wrecking Ball, he understands that the current Amgen Pharmaceutical seems to be a very good opportunity for him.

Moreover, in the few papers he plagiarized in the future, the arguments in them are optimistic about the prospects of biopharmaceuticals, and it is indeed happening in the future.

Gordon S. M. Binder just happened to talk about the direction of the biopharmaceutical future, and he casually responded.

Then continue to read the following information.

Gordon S. M. Binder was happy to see some reaction from Abel.

But I didn't expect this guy to be absent-minded so quickly, he was speechless, but he had to continue to pull investment:

"Dr. George Lasman and Dr. Volt Lin in the company are leaders in the biomedical industry. In particular, Dr. Volt Lin, who and his team successfully researched Epogen, allowed the company to generate more than $20 million in sales in the first month. ”

"This drug is mainly used to treat anemia caused by chronic renal failure. The company can make more than $100 million in profits from this drug every year!"

Gordon S. M. Binder was a bit of a bragging this time, although the new drug was really successful on the market and the sales looked good, but the profits were not as exaggerated as he said.

But now we are looking for investors to attract investment, of course, the more exaggerated the better. Later, in the Internet economy, among the founders who have successfully attracted investment, which one is not a master of bragging and making PPT?

Gordon S. M. Binder is such a, he has already been a little tactful, and he doesn't dare to blow more. The annual profit of about 70 million US dollars can only be said to be more than 100 million US dollars in annual profits. If it were replaced by the Internet founders of later generations, it is estimated that the annual profit of 70 million US dollars could be blown into 7 billion US dollars......

After all, in Internet entrepreneurship, dozens of times the annual profit that does not lose money in the early stage seems to be a failure......

It's a pity that even Gordon M. M. Binder, you think you're blowing a little hard, but Abel is still absent-minded, doesn't seem to be very interested, and doesn't know where to put it.

This made Gordon M. Binder is losing more and more of his spirit and spirit.

How can such an investor invest?

You can bargain, you can argue with reason, and you can name all kinds of advantages and disadvantages...... In this way, Gordon M. M. Binder is also able to find all sorts of reasons to convince the other side.

But the other party now looks completely uninterested, and he is not even bother to listen to himself. M. Binder felt that he could successfully pull in the investment.

"Amgen Pharma attaches great importance to R&D ......"

Speaking of the back.

Gordon S. M. Binder already felt that this time the investment had failed.

He shook his head helplessly, and smiled bitterly in his heart: Hey...... It seems that it has failed again, is it the fifth time this week? the fifth or the sixth time? The two doctors need funding again, but I don't know where to find everyone's salary this week, where am I going to find money for 2 million dollars in new equipment and new vaccine materials?

Maybe you can go to the vampires on Wall Street, who have harsher conditions, but it's easier to get money.

It seems that San Francisco International Airport in the afternoon is a plane that flies directly to JFK, or ...... Try it again with those Wall Street vampires?

Abel looked uninterested.

has made Gordon M. Binder felt in his heart that he had failed, and when he had all found a way back, he was ready to say some farewell words to Abel.

"Mr. Sephorosa......"

Abel, who had just finished reading all the information about Amgen Medicine this year, suddenly spoke: "Mr. Binder." ”

The two men spoke almost at the same time.

Just happened to bump into, and they paused together.

"You speak first!"

"You speak first!"

And then it happened to say the same thing again.

The two men were stunned again.

Laugh together at the end.

Started to really talk.